Results 181 to 190 of about 187,354 (214)

High-titer antinuclear antibodies are associated with severe immune-related toxicity and exploratory survival outcomes in advanced gastric cancer immunotherapy. [PDF]

Ther Adv Med Oncol
Liu W, Tang H, Li N, Qiu W, Li X, Zhao L.   +5 more
europepmc   +1 more source

Chinese consensus on first-line precision therapy for advanced gastric cancer. [PDF]

Innovation (Camb)
Zhang X, Sheng W, Xie T, Peng Z, Liang H, Li E, Wang F, Zhang J, Liu T, Zhu X, Cai M, Wu Y, Deng T, Gou H, Sun Y, Wei J, He Y, Huang D, Ying J, Bai W, Jin X, Kang W, Li N, Li Z, Liu J, Lu Y, Qiu H, Qiu M, Qu X, Song Y, Sun Y, Sun Y, Wang J, Wang Y, Xu H, Yin F, Zhao L, Liu Y, Shen L, Chinese Clinical Society Gastric Cancer Committee, China Anti-Cancer Association Cancer Informatics Management Committee, China Anti-Cancer Association Cancer Pathology Specialized Committee, China Anti-Cancer Association Committee of Cancer Precision Therapy.   +42 more
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Gene-guided repurposing identifies dihydroergotamine as a candidate inhibitor of the BCL2-SIVA1 axis in advanced gastric cancer in vitro. [PDF]

Biol Direct
Huang YL, Lu ZX, Shi ZY, Qiu ZD, Zhong XG, Li L, Xu S, Lei YR, Huang HB, Deng MR, Lu XM, Dong XD, Kong FB, Wang XT.   +13 more
europepmc   +1 more source

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

BMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng, Yunfei Sha, Jiongyan Yang, Hongru Yang, Xiao Liang   +4 more
wiley   +1 more source

Zolbetuximab combined with chemotherapy in a patient with CLDN18.2-positive advanced gastric cancer undergoing hemodialysis: a case report. [PDF]

Front Oncol
Zhao Y, Jin Y, Fu L, Yao D, Zhou Z, Dong Y, Tan Y.   +6 more
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Patient-derived organoids predict chemotherapy response of locally advanced gastric cancer. [PDF]

PLoS One
Huang M, Chu J, Yu W, Dou L, Wang Q, Jiang F, Wei M, Cui X, Zhao W, Zhou J, Li S, Liu L.   +11 more
europepmc   +1 more source

Conversion Surgery for Advanced Gastric Cancer According to First-Line Treatment Strategy: A Single-Center Experience with a Focused Review of the Literature. [PDF]

Cancers (Basel)
Kinoshita J, Doden K, Hayashi K, Matsui R, Saito H, Watanabe M, Tsuji T, Yamamoto D, Inaki N.   +8 more
europepmc   +1 more source